The ‘O-acyl isopeptide method’ for the synthesis of difficult sequence-containing peptides: application to the synthesis of Alzheimer's disease-related amyloid β peptide (Aβ) 1-42
- 1 August 2005
- journal article
- research article
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (8) , 441-451
- https://doi.org/10.1002/psc.649
Abstract
An efficient ‘O‐acyl isopeptide method’ for the synthesis of difficult sequence‐containing peptides was applied successfully to the synthesis of amyloid β peptide (Aβ) 1–42 via a water‐soluble O‐acyl isopeptide of Aβ1–42, i.e. ‘26‐O‐acyl isoAβ1–42’ (6). This paper describes the detailed synthesis of Aβ1–42 focusing on the importance of resin selection and the analysis of side reactions in the O‐acyl isopeptide method. Protected ‘26‐O‐acyl isoAβ1–42’ peptide resin was synthesized using 2‐chlorotrityl chloride resin with minimum side reactions in comparison with other resins and deprotected crude 26‐O‐acyl isoAβ1–42 was easily purified by HPLC due to its relatively good purity and narrow elution with reasonable water solubility. This suggests that only one insertion of the isopeptide structure into the sequence of the 42‐residue peptide can suppress the unfavourable nature of its difficult sequence. The migration of O‐acyl isopeptide to intact Aβ1–42 under physiological conditions (pH 7.4) via ON intramolecular acyl migration reaction was very rapid and no other by‐product formation was observed while 6 was stable under storage conditions. These results concluded that our strategy not only overcomes the solubility problem in the synthesis of Aβ1–42 and can provide intact Aβ1–42 efficiently, but is also applicable in the synthesis of large difficult sequence‐containing peptides at least up to 50 amino acids. This synthesis method would provide a biological evaluation system in Alzheimer's disease research, in which 26‐O‐acyl isoAβ1–42 can be stored in a solubilized form before use and then rapidly produces intact Aβ1–42 in situ during biological experiments. Copyright © 2005 European Peptide Society and John Wiley & Sons, Ltd.Keywords
This publication has 46 references indexed in Scilit:
- Design and synthesis of highly active Alzheimer’s β-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stabilityBioorganic & Medicinal Chemistry Letters, 2005
- O–N Intramolecular acyl migration strategy in water-soluble prodrugs of taxoidsBioorganic & Medicinal Chemistry Letters, 2003
- Synthesis, aggregation, and neurotoxicity of the alzheimer's Aß1-42 amyloid peptide and its isoaspartyl isomersBioorganic & Medicinal Chemistry Letters, 1999
- Pseudo-Prolines as a Solubilizing, Structure-Disrupting Protection Technique in Peptide SynthesisJournal of the American Chemical Society, 1996
- Coupling Difficulty Associated with Interchain Clustering and Phase Transition in Solid Phase Peptide SynthesisJournal of the American Chemical Society, 1995
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- A reversible protecting group for the amide bond in peptides. Use in the synthesis of ‘difficult sequences’Journal of the Chemical Society, Chemical Communications, 1993
- Towards the Chemical Synthesis of ProteinsAngewandte Chemie International Edition in English, 1991
- Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- CHEMICAL SYNTHESIS OF PEPTIDES AND PROTEINSAnnual Review of Biochemistry, 1988